{"id":"https://openalex.org/W2059620437","doi":"https://doi.org/10.2174/138161208784480117","title":"A Critical Evaluation of Adenosine A2A Receptors as Potentially \u201cDruggable\u201d Targets in Huntingtons Disease","display_name":"A Critical Evaluation of Adenosine A2A Receptors as Potentially \u201cDruggable\u201d Targets in Huntingtons Disease","publication_year":2008,"publication_date":"2008-05-01","ids":{"openalex":"https://openalex.org/W2059620437","doi":"https://doi.org/10.2174/138161208784480117","mag":"2059620437","pmid":"https://pubmed.ncbi.nlm.nih.gov/18537673"},"language":"en","primary_location":{"id":"doi:10.2174/138161208784480117","doi":"https://doi.org/10.2174/138161208784480117","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161208784480117","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012134128","display_name":"Patrizia Popoli","orcid":"https://orcid.org/0000-0002-9064-0639","observed_orcids":["https://orcid.org/0000-0002-9064-0639"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Patrizia Popoli","raw_affiliation_strings":["Section of Central Nervous System Pharmacology, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome, Italy. patrizia.popoli@iss.it","Section of Central Nervous System Pharmacology, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Central Nervous System Pharmacology, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome, Italy. patrizia.popoli@iss.it","institution_ids":["https://openalex.org/I27897274"]},{"raw_affiliation_string":"Section of Central Nervous System Pharmacology, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanit\u00e0, Rome, Italy","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053472629","display_name":"David L Blum","orcid":"https://orcid.org/0000-0001-5691-431X","observed_orcids":["https://orcid.org/0000-0001-5691-431X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Blum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055622646","display_name":"Maria Rosaria Domenici","orcid":"https://orcid.org/0000-0001-5552-4061","observed_orcids":["https://orcid.org/0000-0001-5552-4061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Domenici","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083292071","display_name":"Sylvie Burnouf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvie Burnouf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018776391","display_name":"Yijuang Chern","orcid":"https://orcid.org/0000-0002-5842-5429","observed_orcids":["https://orcid.org/0000-0002-5842-5429"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Yijuang Chern","raw_affiliation_strings":["Section of Central Nervous System Pharmacology, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanita, Rome, Italy.,Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Central Nervous System Pharmacology, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanita, Rome, Italy.,Italy","institution_ids":["https://openalex.org/I27897274"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5018776391"],"corresponding_institution_ids":["https://openalex.org/I27897274"],"apc_list":null,"apc_paid":null,"fwci":3.0323,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.90985182,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"14","issue":"15","first_page":"1500","last_page":"1511"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.9351000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.9351000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.026000000536441803,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":0.9700000286102295},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9300000071525574},{"id":"https://openalex.org/keywords/druggable-targets","display_name":"druggable targets","score":0.8859999775886536},{"id":"https://openalex.org/keywords/basal-ganglia","display_name":"basal ganglia","score":0.9710000157356262},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.75},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8679999709129333},{"id":"https://openalex.org/keywords/mutant-huntingtin","display_name":"mutant huntingtin","score":0.7570000290870667},{"id":"https://openalex.org/keywords/cag-trinucleotide-repeat","display_name":"CAG trinucleotide repeat","score":0.8450000286102295},{"id":"https://openalex.org/keywords/receptor-agonists-and-antagonists","display_name":"receptor agonists and antagonists","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C2781427258","wikidata":"https://www.wikidata.org/wiki/Q2620886","display_name":"Huntingtin","level":4,"score":0.8537296056747437},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6583216190338135},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.6455940008163452},{"id":"https://openalex.org/C2778491162","wikidata":"https://www.wikidata.org/wiki/Q3063865","display_name":"Adenosine A2A receptor","level":5,"score":0.5992002487182617},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5874878764152527},{"id":"https://openalex.org/C2777616661","wikidata":"https://www.wikidata.org/wiki/Q7226416","display_name":"Polyglutamine tract","level":5,"score":0.5389997959136963},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.5371684432029724},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.522413969039917},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.48500415682792664},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.45722997188568115},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.44277578592300415},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.36033493280410767},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34427547454833984},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31395500898361206},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27382540702819824},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2235088050365448},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.22218436002731323},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20099765062332153},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.19743478298187256},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.07253476977348328},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06842347979545593}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006816","descriptor_name":"Huntington Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006816","descriptor_name":"Huntington Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D043705","descriptor_name":"Receptor, Adenosine A2A","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058908","descriptor_name":"Adenosine A2 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/138161208784480117","doi":"https://doi.org/10.2174/138161208784480117","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161208784480117","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:18537673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18537673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320893","display_name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","ror":"https://ror.org/02vjkv261"},{"id":"https://openalex.org/F4320321040","display_name":"National Science Council","ror":"https://ror.org/02kv4zf79"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2318834865","https://openalex.org/W2115863361","https://openalex.org/W2070782694","https://openalex.org/W2135061224","https://openalex.org/W3133991056","https://openalex.org/W2343579832","https://openalex.org/W2803288586","https://openalex.org/W6979846737","https://openalex.org/W1994426409","https://openalex.org/W2962593823"],"abstract_inverted_index":{"Huntington's":[0],"disease":[1],"(HD)":[2],"is":[3,112,185],"a":[4,14,20,52,74,139,195],"dominantly":[5],"inherited":[6],"neurodegenerative":[7,127],"disorder":[8],"caused":[9],"by":[10,115],"the":[11,24,31,36,46,100,104,116,123,133],"expansion":[12],"of":[13,30,39,41,61,95,99,103,129,149,165,182],"polymorphic":[15],"CAG":[16],"trinucleotide":[17],"repeat":[18],"encoding":[19],"poly-glutamine":[21],"tract":[22],"within":[23],"Huntingtin":[25],"protein.":[26],"GABAergic":[27],"enkephalin":[28],"neurons":[29],"basal":[32],"ganglia,":[33],"which":[34,56,168],"show":[35],"highest":[37],"levels":[38],"expression":[40,60,85],"adenosine":[42,69,190],"A(2A)":[43,70,83,106,170,191],"receptors,":[44],"are":[45],"most":[47],"vulnerable":[48],"in":[49,77,82,91,109,132,154,162,167],"HD.":[50,78,96,202],"Such":[51],"selective":[53],"neuronal":[54],"vulnerability,":[55],"occurs":[57],"despite":[58],"ubiquitous":[59],"mutant":[62],"and":[63,86,126,143,173],"normal":[64],"Huntingtin,":[65],"has":[66,160],"suggested":[67],"that":[68],"receptors":[71,131,192],"might":[72],"play":[73],"pathogenetic":[75,141],"role":[76,142],"In":[79],"agreement,":[80],"changes":[81],"receptor":[84,107,171],"signaling":[87],"have":[88,175],"been":[89],"reported":[90,121],"various":[92],"experimental":[93,163],"models":[94,164],"The":[97,156,179],"interpretation":[98],"functional":[101],"significance":[102],"aberrant":[105],"phenotype":[108],"HD":[110],"mice":[111],"however":[113],"complicated":[114],"conflicting":[117],"data":[118,137,146],"so":[119],"far":[120],"on":[122],"potential":[124,140],"neuroprotective":[125],"effects":[128],"these":[130],"brain,":[134],"with":[135],"some":[136,144],"suggesting":[138,147],"other":[145],"activation":[148],"trophic":[150],"or":[151],"protective":[152],"pathways":[153],"neurons.":[155],"same":[157],"complex":[158],"profile":[159],"emerged":[161],"HD,":[166],"both":[169],"agonists":[172],"antagonists":[174],"shown":[176],"beneficial":[177],"effects.":[178],"main":[180],"aim":[181],"this":[183],"review":[184],"to":[186,198],"critically":[187],"evaluate":[188],"whether":[189],"may":[193],"represent":[194],"suitable":[196],"target":[197],"develop":[199],"drugs":[200],"against":[201]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}